Eric Shroff's most recent trade in Abbott Laboratories was a trade of 1,384 Common shares without par value done at an average price of $116.3 . Disclosure was reported to the exchange on Feb. 27, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Abbott | Eric Shroff | Senior Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 116.26 per share. | 27 Feb 2026 | 1,384 | 39,873 (0%) | 0% | 116.3 | 160,904 | Common shares without par value |
| Abbott | Eric Shroff | Senior Vice President | Sale of securities on an exchange or to another person at price $ 115.58 per share. | 27 Feb 2026 | 709 | 39,164 (0%) | 0% | 115.6 | 81,946 | Common shares without par value |
| Abbott | Eric Shroff | Senior Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2026 | 44,821 | 44,821 | - | - | Option (right to buy) | |
| Abbott | Eric Shroff | Senior Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2026 | 10,873 | 41,257 (0%) | 0% | 0 | Common shares without par value | |
| Abbott | Eric Shroff | Senior Vice President | Sale of securities on an exchange or to another person at price $ 128.02 per share. | 25 Nov 2025 | 1,586 | 30,384 (0%) | 0% | 128.0 | 203,043 | Common shares without par value |
| Abbott | Eric Shroff | Senior Vice President | Sale of securities on an exchange or to another person at price $ 138.17 per share. | 03 Mar 2025 | 562 | 31,970 (0%) | 0% | 138.2 | 77,652 | Common shares without par value |